Abiopharma

IFF擴建格拉斯LMR Naturals基地，鞏固天然成分創新領導地位

IFF扩建格拉斯LMR Naturals基地，巩固天然成分创新领导地位

IFF breidt de vestiging LMR Naturals in Grasse uit om haar leiderschap op het vlak van innovatie van natuurlijke bestanddelen te versterken

IFF espande il sito di LMR Naturals a Grasse e consolida la propria posizione di leader nellinnovazione dei prodotti naturali

IFF amplía la planta de LMR Naturals en Grasse, impulsando el liderazgo en innovación natural

RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025

Vinczeller Shiela 🔴 sold 1.2K shares of APTARGROUP, INC. (ATR) at $137.97 Transaction Date: Sep 05, 2025 | Filing ID: 015381

New Form 144 - Ginkgo Bioworks Holdings, Inc. Filed: 2025-09-08 AccNo: 0001959173-25-005824 Size: 7 KB

SC 13G/A (Amended Statement of Ownership) SEC Filing

Dizon Romeo R 🟢 acquired 1.0K shares of IRIDEX CORP (IRIX) at $1.35 Transaction Date: Sep 05, 2025 | Filing ID: 113407

Bristol Myers Squibb - First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

New Form SCHEDULE 13G/A - Sarepta Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0000932471-25-001161 Size: 6 KB

New Form SCHEDULE 13G/A - AMGEN INC Filed: 2025-09-08 AccNo: 0000932471-25-001153 Size: 6 KB

Prenetics’ IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity